Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|December 15, 2012
The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205Mai N Tran, Woonyoung Choi, Matthew F Wszolek, et al.
Urologic Oncology|February 10, 2021
Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray projectGang Wang, Peter C Black, Peter J Goebell, et al.
International Journal of Cancer|October 9, 2004
Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignanciesHisayuki Shigematsu, Makoto Suzuki, Takao Takahashi, et al.
Communications Biology|November 28, 2020
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapyMegan M Tu, Hany A Abdel-Hafiz, Robert T Jones, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Combined Mek inhibition and <i>Pparg</i> activation Eradicates Muscle Invasive Bladder cancer in a Mouse Model of BBN-induced CarcinogenesisTiffany Tate, Sakina A Plumber, Hikmat Al-Ahmadie, et al.
Cancer Research|September 17, 2008
Cytoglobin, the newest member of the globin family, functions as a tumor suppressor geneNarayan Shivapurkar, Victor Stastny, Naoki Okumura, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomasKanishka Sircar, Suk-Young Yoo, Tadeusz Majewski, et al.
The Journal of Urology|August 6, 2013
Refining patient selection for neoadjuvant chemotherapy before radical cystectomyStephen H Culp, Rian J Dickstein, H Barton Grossman, et al.
Molecular Cancer Research : MCR|March 4, 2020
TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder CancerSharada Mokkapati, Sima P Porten, Vikram M Narayan, et al.
Pageof 11